AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Gentian Diagnostics ASA

Director's Dealing • Dec 19, 2019

3604_dirs_2019-12-19_cce03d57-51b9-4938-a3a3-b61d90ae97be.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Gentian Diagnostics AS – Primary insider notification

(Oslo, Norway, December 19, 2019) A closely related party to Runar Vatne, which is a Board Member and primary insider of Gentian Diagnostics AS, has today bought 2,000 shares in Gentian Diagnostics AS at price of NOK 54.926 per share.

Following the share purchase, Runar Vatne and closely related parties indirectly hold 2,232,224 shares in Gentian Diagnostics AS, corresponding to 14.5% of the outstanding shares.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Further information

Jens Borge-Andersen

Chief Financial Officer, Vatne Capital AS

E-mail: [email protected] Cell Phone: +47 95 75 60 10